The thing I find very interesting is that looking at PNV and their publications page there are 17 studies on complex wounds, 3 on necrotising fasciitis, and 25 on burns - all from a diversity of researchers. Looking at one competitor that uses a biologic, they only have 6 published articles all from pretty much the same people.
Market has no idea the nuances of the products and I know where I am confident in putting my money, particularly as the evidence clearly demonstrates.
PNV - Banter and General Comments, page-7056
-
- There are more pages in this discussion • 5,236 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.46 |
Change
-0.030(1.20%) |
Mkt cap ! $1.699B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.38 | $5.046M | 2.064M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12469 | $2.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 499 | 1 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |